Nutritional Management of Dwarfism
DOI:
https://doi.org/10.37591/(rrjops).v14i2.1330Keywords:
Nutrition, Dwarfism, Diet, Growth hormone, Genetic, Protein.Abstract
Early childhood PROTEIN-CALORIE malnutrition is the most prevalent nutritional condition, especially in emerging nations and among disadvantaged people. The primary issue appears to be dietary intake of insufficient good quality protein to meet requirements for growth, resistance, and repair, as well as a low or disproportionately high intake of calories from carbohydrates, despite the possibility of many different synergistic factors influencing its occurrence and manifestations. For many years, the most severe cases of protein calorie malnutrition—particularly kwashiorkor and nutritional marasmus—have been the main focus of research efforts. These advanced major syndromes, which represent one end of the clinical continuum and have significant mortality rates, have dominated interest in the mild forms, which, in contrast, are so subtle and poorly characterized that they are routinely disregarded. Yet, dietary protein deficiency is a much bigger issue than the prevalence rates for the full-blown disorders suggest. During the first three years of life, when growth needs are at their highest, even a little protein intake deficit may result in a perilous nutritional imbalance, and if it persists, it may have an irreparable impact on both physical growth and mental development. To improve accuracy, impartiality, and facility in identifying affected children and in monitoring sensitive groups in regions of low protein intake, a more precise clinical and laboratory description of early stages and minor symptoms is required. In this study, children under the age of three experienced the appearance and characteristics of nutritional dwarfing, a syndrome of early protein-calorie malnutrition. The methods utilised in this study to evaluate a child's growth and nutrition might be beneficial in monitoring young children in different areas.References
Torun B, Viteri FE. Protein energy malnutrition. In: Shils ME, Young VR, eds. Modern nutrition in health and disease. 7th ed. Philadelphia: Lea & Febiger, 1988:746-73.
McLaren, D. S., & Read, W. W. C. (1973). Assessment of nutritional status of children. The Lancet, 302(7825), 374-375.
Nickens, P. R. (1976). Stature reduction as an adaptive response to food production in Mesoamerica. Journal of Archaeological Science, 3(1), 31-41.
Food and Agriculture Organization of the United Nations, United Nations Children’s Fund, World Health Organization. Methodology of nutritional surveillance. Report of a joint FAOlUNICEFiWHO expert committee. Technical report series, no 593. Geneva: World Health Organization, 1976.
Sandberg DE, Smith MM, Fornari V, Goldstein M, Lifshitz F. Nutritional dwarfing: is it a consequence of disturbed psychosocial functioning? Pediatrics. 1991 Nov;88(5):926-33. PMID: 1945633.
Mary Anne Dunkin. “Dwarfism.” WebMD. WebMD, November 16, 2010. https://www.webmd.com/children/dwarfism-causes-treatments.
“Prevalence | Risk Factors, Causes & Consequences | Britannica.” In EncyclopædiaBritannica,2023.https://www.britannica.com/science/prevalence.
Kerrigan JR, Rogol AD. The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. Endocr Rev. 1992 May;13(2):281-98. [PubMed]
Nilsson O, Weise M, Landman EB, Meyers JL, Barnes KM, Baron J. Evidence that estrogen hastens epiphyseal fusion and cessation of longitudinal bone growth by irreversibly depleting the number of resting zone progenitor cells in female rabbits. Endocrinology. 2014 Aug;155(8):2892-9. [PMC free article] [PubMed]
Sederquist B, Fernandez-Vojvodich P, Zaman F, Sävendahl L. Recent research on the growth plate: Impact of inflammatory cytokines on longitudinal bone growth. J Mol Endocrinol. 2014 Aug;53(1):T35-44. doi: 10.1530/JME-14-0006. Epub 2014 Apr 7.
Binder, Gerhard, and Gudrun A Rappold. “SHOX Deficiency Disorders.” Nih.gov. University of Washington, Seattle, June 28, 2018. https://www.ncbi.nlm.nih.gov/books/NBK1215/.
Unger, S., L. Bonafé, and E. Gouze, Current Care and Investigational Therapies in Achondroplasia. Current Osteoporosis Reports, 2017. 15(2): p. 53-60.
Wynn, J., et al., Mortality in achondroplasia study: A 42-year follow-up. American Journal of Medical Genetics Part A, 2007. 143A(21): p. 2502-2511.
Ireland, P.J., et al., Optimal management of complications associated with achondroplasia. The Application of Clinical Genetics, 2014. 7: p. 117-125
Hoover-Fong, J.E., et al., Weight for age charts for children with achondroplasia. American Journal of Medical Genetics Part A, 2007. 143A(19): p. 2227-2235
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |